×
References
1) Klag KA, Horton WA. Advances in treatment of achondroplasia and osteoarthritis. Hum Mol Genet. 2016 Apr 15;25(R1):R2-8. doi: 10.1093/hmg/ddv419. Epub 2015 Oct 6. Review. PubMed PMID: 26443596.
2) Pauli RM. Achondroplasia. ?1998 Oct 12 [updated 2012 Feb 16]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016.
3) Bouali H, Latrech H. Achondroplasia: Current Options and Future Perspective. Pediatr Endocrinol Rev. 2015 Jun;12(4):388-95. Review. PubMed PMID: 26182483.
4) Horton, W.A., Hall, J.G. and Hecht, J.T. (2007) Achondroplasia. Lancet, 370, 162–172.
5) Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P., Le Merrer, M. and Munnich, A. (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature, 371, 252–254.?
6) Shiang, R., Thompson, L.M., Zhu, Y.Z., Church, D.M., Fielder, T.J., Bocian, M., Winokur, S.T. and Wasmuth, J.J. (1994) Muta- tions in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell, 78, 335–342.?
7) Langer LO, Baumann PA, Gorlin RJ. Achondroplasia. Am J Roentgenol Radium Ther Nucl Med. 1967;100:12–26.
8) Pauli RM. Achondroplasia. In Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. 3 ed. New York, NY: John Wiley & Sons. 2010:17-37.